Scarlet Fever

BASICS

BASICS

BASICS

DESCRIPTION

DESCRIPTION

DESCRIPTION

  • A disease (typically in childhood) characterized by fever, pharyngitis, and rash caused by group A β-hemolytic Streptococcus pyogenes (GAS) that produces erythrogenic toxin
  • Incubation period: 1 to 7 days
  • Duration of illness: 4 to 10 days
  • Rash (erythematous, blanchable 1 to 2 mm papules; “sand paper”) usually appears within 24 to 48 hours after symptom onset.
  • Rash first appears in the groin, trunk, and axillae accompanied by strawberry tongue and circumoral pallor and then rapidly spreads outward all over the body, sparing palms and soles.
  • Rash clears at the end of the 1st week and is followed by several weeks of desquamation.
  • Rash is not dangerous but is a marker for GAS infection with suppurative and nonsuppurative complications.
  • System(s) affected: head, eyes, ears, nose, throat, skin/exocrine
  • Synonym(s): scarlatina

EPIDEMIOLOGY

EPIDEMIOLOGY

EPIDEMIOLOGY

Incidence

Incidence

Incidence

  • In developed countries, 15% of school-aged children and 4–10% of adults have an episode of GAS pharyngitis each year.
  • Scarlet fever is rare in infancy because of maternal antitoxin antibodies.
  • Predominant age: 6 to 12 years
  • Peak age: 4 to 8 years
  • Predominant sex: male = female
  • Rare in the United States in persons aged >12 years because of high rates (>80%) of lifelong protective antibodies to erythrogenic toxins

Prevalence

Prevalence

Prevalence

  • 15–30% of cases of pharyngitis in children are due to GAS; 5–15% in adults
  • <10% of children with streptococcal pharyngitis develop scarlet fever.

ETIOLOGY AND PATHOPHYSIOLOGY

ETIOLOGY AND PATHOPHYSIOLOGY

ETIOLOGY AND PATHOPHYSIOLOGY

  • Erythrogenic toxin production is necessary for scarlet fever to develop clinically.
  • Three toxin types: A, B, C
  • Toxins damage capillaries (producing rash) and act as superantigens, stimulating cytokine release.
  • Antibodies to toxins prevent development of rash but do not protect against underlying infection.
  • Primary site of streptococcal infection is usually within the tonsils, but scarlet fever may also occur with infection of skin, surgical wounds, or uterus (puerperal scarlet fever).

RISK FACTORS

RISK FACTORS

RISK FACTORS

  • Winter/early spring seasonal increase
  • More common in school-aged children
  • Contact with infected individual(s)
  • Crowded living conditions (e.g., lower socioeconomic status, barracks, child care, schools)

GENERAL PREVENTION

GENERAL PREVENTION

GENERAL PREVENTION

  • Spread by contact with airborne respiratory droplets, saliva, and nasal secretions
  • Foodborne outbreaks have been reported but are rare.
  • Asymptomatic contacts do not require cultures/prophylaxis.
  • Symptomatic contacts of a child with documented GAS infection who have recent or current clinical evidence of a GAS infection should undergo appropriate laboratory tests and should be treated if test results are positive.
  • Children should not return to school/daycare until they are afebrile and have received 24 hours of antibiotic therapy.

COMMONLY ASSOCIATED CONDITIONS

COMMONLY ASSOCIATED CONDITIONS

COMMONLY ASSOCIATED CONDITIONS

  • Pharyngitis
  • Impetigo
  • Rheumatic fever
  • Glomerulonephritis

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.